MENU
RGNX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
REGENXBIO (RGNX) Earnings Date & Reports
Regenxbio Inc is a clinical-stage biotechnology company focused on the development of gene therapy treatments... Show more
Industry: #Biotechnology
A.I. Advisor
published Earnings
RGNX is expected to report earnings to fall 114.35% to 24 cents per share on August 05
Q2'26
Est.
$0.25
Q1'26
Missed
by $0.38
Q4'25
Missed
by $0.58
Q3'25
Beat
by $0.10
Q2'25
Missed
by $0.44
The last earnings report on May 14 showed earnings per share of -172 cents, missing the estimate of -134 cents. With 592.39K shares outstanding, the current market capitalization sits at 316.65M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information
General Information
a developer of gene therapy treatments
Industry Biotechnology
Profile
Details
Industry
Biotechnology
Address
9804 Medical Center Drive
Phone
+1 240 552-8181
Employees
371
Web
https://www.regenxbio.com